[go: up one dir, main page]

WO2002002811A3 - Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie - Google Patents

Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie Download PDF

Info

Publication number
WO2002002811A3
WO2002002811A3 PCT/FR2001/002191 FR0102191W WO0202811A3 WO 2002002811 A3 WO2002002811 A3 WO 2002002811A3 FR 0102191 W FR0102191 W FR 0102191W WO 0202811 A3 WO0202811 A3 WO 0202811A3
Authority
WO
WIPO (PCT)
Prior art keywords
organisms
micro
microbiological
medium
microbiological quality
Prior art date
Application number
PCT/FR2001/002191
Other languages
English (en)
Other versions
WO2002002811A2 (fr
WO2002002811B1 (fr
Inventor
Patricia Renaud
Emmanuelle Guillot
Claude Mabilat
Carole Vachon
Bruno Lacroix
Guy Vernet
Marie-Astrid Armand
Philippe Laffaire
Original Assignee
Bio Merieux
Patricia Renaud
Emmanuelle Guillot
Claude Mabilat
Carole Vachon
Bruno Lacroix
Guy Vernet
Marie-Astrid Armand
Philippe Laffaire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux, Patricia Renaud, Emmanuelle Guillot, Claude Mabilat, Carole Vachon, Bruno Lacroix, Guy Vernet, Marie-Astrid Armand, Philippe Laffaire filed Critical Bio Merieux
Priority to EP01951777A priority Critical patent/EP1317565A2/fr
Priority to US10/332,123 priority patent/US20040072239A1/en
Priority to JP2002507055A priority patent/JP2004533204A/ja
Priority to CA002412946A priority patent/CA2412946A1/fr
Priority to BR0112163-4A priority patent/BR0112163A/pt
Priority to AU2001272629A priority patent/AU2001272629A1/en
Publication of WO2002002811A2 publication Critical patent/WO2002002811A2/fr
Publication of WO2002002811A3 publication Critical patent/WO2002002811A3/fr
Publication of WO2002002811B1 publication Critical patent/WO2002002811B1/fr
Priority to US12/010,716 priority patent/US20080171314A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procédé de contrôle de la qualité microbiologique d'un milieu aqueux environnemental, susceptible de comporter différents micro-organismes, comprenant les étapes suivantes: on choisit un ensemble de référence, constitué d'au moins trois micro-organismes, représentatifs, ensemble ou séparément, d'un niveau de qualité microbiologique, on dispose d'un nécessaire de détermination microbiologique, constitué d'au moins trois sondes d'identification spécifiquement et respectivement desdits trois microorganismes, après traitement du milieu à analyser, on met lesdits microorganismes, ou toute fraction obtenue à partir de ces derniers, en contact avec ledit nécessaire de détermination, moyennant quoi on multi-détermine lesdits microorganismes, cette détermination étant représentative du niveau de qualité microbiologique du milieu. Nécessaire de détermination microbiologique approprié pour la mise en oeuvre du procédé de l'invention.
PCT/FR2001/002191 2000-07-06 2001-07-06 Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie WO2002002811A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP01951777A EP1317565A2 (fr) 2000-07-06 2001-07-06 Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie
US10/332,123 US20040072239A1 (en) 2000-07-06 2001-07-06 Method for controlling the microbiological quality of an aqueous medium and kit therefor
JP2002507055A JP2004533204A (ja) 2000-07-06 2001-07-06 水性媒体の微生物学的品質の管理方法及びそれ用のキット
CA002412946A CA2412946A1 (fr) 2000-07-06 2001-07-06 Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie
BR0112163-4A BR0112163A (pt) 2000-07-06 2001-07-06 Processos de controle da qualidade microbiológica de um meio aquoso ambiental, kit de detecção microbiológica de um microorganismo presente em uma amostra e processo de produção e/ou desinfecção de um lìquido
AU2001272629A AU2001272629A1 (en) 2000-07-06 2001-07-06 Method for controlling the microbiological quality of an aqueous medium and kit therefor
US12/010,716 US20080171314A1 (en) 2000-07-06 2008-01-29 Method for controlling the microbiological quality of an aqueous medium and kit therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008839 2000-07-06
FR00/08839 2000-07-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/010,716 Division US20080171314A1 (en) 2000-07-06 2008-01-29 Method for controlling the microbiological quality of an aqueous medium and kit therefor

Publications (3)

Publication Number Publication Date
WO2002002811A2 WO2002002811A2 (fr) 2002-01-10
WO2002002811A3 true WO2002002811A3 (fr) 2003-03-20
WO2002002811B1 WO2002002811B1 (fr) 2004-03-04

Family

ID=8852205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/002191 WO2002002811A2 (fr) 2000-07-06 2001-07-06 Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie

Country Status (10)

Country Link
US (2) US20040072239A1 (fr)
EP (1) EP1317565A2 (fr)
JP (1) JP2004533204A (fr)
CN (1) CN1451050A (fr)
AU (1) AU2001272629A1 (fr)
BR (1) BR0112163A (fr)
CA (1) CA2412946A1 (fr)
NZ (1) NZ552462A (fr)
SG (1) SG144729A1 (fr)
WO (1) WO2002002811A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143314D1 (de) 2000-09-12 2010-12-02 Gen Probe Inc Estimmung der präsenz von cryptosporidium organismen in einer testprobe
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
WO2004060278A2 (fr) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Procedes d'identification rapide de pathogenes chez l'homme et les betes
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
JP2004313181A (ja) 2003-04-02 2004-11-11 Canon Inc 感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
DE10320519A1 (de) * 2003-04-30 2004-11-25 4Base Lab Gmbh Advanced Molecular Analysis Verfahren zum Nachweis infektiöser (+)-Strang-RNA-Viren, insbesondere infektiöser Enteroviren
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20080311556A1 (en) * 2003-08-07 2008-12-18 Iversen Patrick L Sense Antiviral Compound and Method for Treating Ssrna Viral Infection
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8394945B2 (en) 2003-09-11 2013-03-12 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
CA2567839C (fr) 2004-05-24 2011-06-28 Isis Pharmaceuticals, Inc. Spectrometrie de masse a filtration ionique selective par seuillage numerique
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (fr) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Procedes pour l'identification rapide d'organismes recombinants
US8129352B2 (en) 2004-09-16 2012-03-06 Avi Biopharma, Inc. Antisense antiviral compound and method for treating ssRNA viral infection
US8357664B2 (en) 2004-10-26 2013-01-22 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
EP1869180B1 (fr) 2005-03-03 2013-02-20 Ibis Biosciences, Inc. Compositions utilisées pour identifier des virus polyoma
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
AU2006272776B2 (en) 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
WO2007030691A2 (fr) * 2005-09-08 2007-03-15 Avi Biopharma, Inc. Compose antisens antiviral et procede de traitement d'infection picornavirale
US8329668B2 (en) * 2005-09-08 2012-12-11 Avi Biopharma, Inc. Antisense antiviral compound and method for treating picornavirus infection
WO2007047912A2 (fr) * 2005-10-17 2007-04-26 Gen-Probe Incorporated Compositions et procedes destines a detecter des acides nucleiques de legionella pneumophila
US8609829B2 (en) * 2005-10-17 2013-12-17 Gen-Probe Incorporated Compositions and methods to detect Legionella pneumophila nucleic acid
CN100447253C (zh) * 2005-10-26 2008-12-31 山东省医药生物技术研究中心 一种同时检测a、b、c三组人轮状病毒的玻璃基因芯片及制备方法与应用
CN100412205C (zh) * 2005-10-26 2008-08-20 山东省医药生物技术研究中心 一种同时检测a、b、c三组人轮状病毒的膜基因芯片及制备方法与应用
US8501704B2 (en) 2005-11-08 2013-08-06 Sarepta Therapeutics, Inc. Immunosuppression compound and treatment method
US8741565B2 (en) * 2005-12-30 2014-06-03 Honeywell International Inc. Oligonucleotide microarray for identification of pathogens
US8785407B2 (en) * 2006-05-10 2014-07-22 Sarepta Therapeutics, Inc. Antisense antiviral agent and method for treating ssRNA viral infection
US8032234B2 (en) 2006-05-16 2011-10-04 Rosemount Inc. Diagnostics in process control and monitoring systems
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (fr) 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Procédé d'analyse d'adn médico-légale rapide
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
CN101801993A (zh) * 2007-07-17 2010-08-11 拉瓦勒大学 用于扩增和检测呼吸道病毒的核酸序列
EP2347254A2 (fr) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Unités de traitement d'échantillons, systèmes et procédés associés
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
WO2010057069A1 (fr) 2008-11-14 2010-05-20 Gen-Probe Incorporated Compositions, kits et procédés pour la détection d’acide nucléique de campylobacter
EP2396803A4 (fr) 2009-02-12 2016-10-26 Ibis Biosciences Inc Ensembles sonde d'ionisation
WO2010138973A2 (fr) * 2009-05-29 2010-12-02 Phthisis Diagnostics Détection et criblage améliorés de pathogènes
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
BR112012011381B8 (pt) 2009-11-13 2021-05-25 Avi Biopharma Inc oligonucleotídeo antisenso antiviral isolado e composição farmacêutica compreendendo o mesmo
US8198429B2 (en) 2010-08-09 2012-06-12 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
US10190177B2 (en) * 2014-08-01 2019-01-29 The Curators Of The University Of Missouri Multiplex assay for detection of bacterial species in biological samples
JP7197676B2 (ja) * 2019-03-04 2022-12-27 三井化学株式会社 細胞壁を有する生物の存在状態の判定方法、及び細胞壁を有する生物の同定方法
CN117625480B (zh) * 2023-11-30 2024-05-31 吉林农业大学 一株粪肠球菌及其在抗猪轮状病方面的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0438115A2 (fr) * 1990-01-19 1991-07-24 F. Hoffmann-La Roche Ag Procédé pour la détection des pathogènes microbiens aqueuses et l'indicateur de la contamination fécale humaine dans des échantillons aqueuses et kits pour cela
WO1997042349A1 (fr) * 1996-05-09 1997-11-13 Metropolitan Water District Of Southern California Procede de detection de cryptosporidium

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2618820B2 (ja) * 1992-05-18 1997-06-11 ミンテック コーポレーション 中空繊維フィルターカートリッジおよび製造方法
JP4468488B2 (ja) * 1996-05-29 2010-05-26 コーネル・リサーチ・ファンデーション・インコーポレイテッド 組み合せたリガーゼ検出およびポリメラーゼ連鎖反応を用いる核酸配列相違の検出
FR2766825B1 (fr) * 1997-08-04 2001-04-13 Pasteur Institut Oligonucleotide specifique de l'espece escherichia coli et procede de detection et de visualisation des bacteries de cette espece
US6258570B1 (en) * 1998-04-17 2001-07-10 University Of Pittsburgh PCR assay for bacterial and viral meningitis
US20030032029A1 (en) * 1998-12-21 2003-02-13 Nanogen, Inc. Three dimensional apparatus and method for integrating sample preparation and multiplex assays
DK1259643T3 (da) * 2000-02-07 2009-02-23 Illumina Inc Fremgangsmåde til detektion af nukleinsyre ved anvendelse af universel priming
US7582420B2 (en) * 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US6562575B1 (en) * 2000-06-26 2003-05-13 Epicentre Technologies Corporation Analyte-specific assays based on formation of a replicase substrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0438115A2 (fr) * 1990-01-19 1991-07-24 F. Hoffmann-La Roche Ag Procédé pour la détection des pathogènes microbiens aqueuses et l'indicateur de la contamination fécale humaine dans des échantillons aqueuses et kits pour cela
US5298392A (en) * 1990-01-19 1994-03-29 Hoffmann-La Roche Inc. Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor
WO1997042349A1 (fr) * 1996-05-09 1997-11-13 Metropolitan Water District Of Southern California Procede de detection de cryptosporidium

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BEJ A K ET AL.: "Detection of coliform bacteria and Escherichia coli by multiplex polymerase chain reaction: Comparison with defined substrate and plating methods for water quality monitoring", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 57, no. 8, 1991, pages 2429 - 2432, XP001004829 *
BELGRADER P ET AL.: "Rapid pathogen detection using a microchip PCR array instrument", CLINICAL CHEMISTRY, vol. 44, no. 10, 1998, pages 2191 - 2194, XP001006169 *
CATALAN V ET AL.: "Rapidness and reliability: important factors in the actual and future development of the microbiological control of water", WATER SUPPLY, vol. 18, no. 1-2, 2000, pages 446 - 449, XP001004833 *
DELPECH M: "Les puces à ADN", ANNALES DE BIOLOGIE CLINIQUE, vol. 58, February 2000 (2000-02-01), pages 29 - 38, XP001006165 *
GRABOW W O K: "Waterborne diseases: Update on water quality assessment and control", WATER SA, vol. 22, no. 2, April 1996 (1996-04-01), pages 193 - 202, XP001004831 *
KONG R Y C ET AL: "CO-DETECTION OF THREE SPECIES OF WATER-BORNE BACTERIA BY MULTIPLEX PCR", MARINE POLLUTION BULLETIN,GB,OXFORD, vol. 31, no. 4/12, 1 April 1995 (1995-04-01), pages 317 - 324, XP002064700, ISSN: 0025-326X *

Also Published As

Publication number Publication date
US20080171314A1 (en) 2008-07-17
CA2412946A1 (fr) 2002-01-10
BR0112163A (pt) 2004-02-10
CN1451050A (zh) 2003-10-22
SG144729A1 (en) 2008-08-28
WO2002002811A2 (fr) 2002-01-10
WO2002002811B1 (fr) 2004-03-04
AU2001272629A1 (en) 2002-01-14
EP1317565A2 (fr) 2003-06-11
US20040072239A1 (en) 2004-04-15
JP2004533204A (ja) 2004-11-04
NZ552462A (en) 2008-09-26

Similar Documents

Publication Publication Date Title
WO2002002811A3 (fr) Procede de controle de la qualite microbiologique d'un milieu aqueux et necessaire approprie
WO2006020579A3 (fr) Procede d'identification rapide de micro-organismes
WO2001048237A3 (fr) Procede de determination rapide de dns/rns microbiens, kit y relatif et utilisation du procede
EP1383914A4 (fr) Procede perfectionne de detection de l'atp
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2002008461A3 (fr) Methodes d'analyse et d'identification de genes transcrits et empreinte genetique
WO2002044418A3 (fr) Analyse de l'expression des acides nucleiques fkbp et polypeptides utiles dans le diagnostic et le traitement du cancer de la prostate
ATE171220T1 (de) Verfahren zur kolorimetrischen bestimmung eines analyten mit einer pqq-abhängigen dehydrogenase
EP1310793A4 (fr) Coffret d'activation de substrat et procede de detection d'adn ou similaire a l'aide dudit coffret
WO2000075363A3 (fr) Mesure enzymatique de l'acide mycophenolique
WO1998014611A3 (fr) Detection et identification d'enterovirus non poliovirus
WO2003048383A3 (fr) Effecteurs d'immunite innee
HK1039965A1 (zh) 用於檢測cryptosporidium parvum的方法和試劑盒
WO2003018838A3 (fr) Detection d'interactions sur des ensembles de sondes
CA2407760A1 (fr) Methodes pour le diagnostic de l'astrocytome de bas grade
Bark et al. Polyphosphate-dependent enzymes in some coryneform bacteria isolated from sewage sludge
WO2002103043A3 (fr) Procede pour la mise en evidence rapide specifique de bacteries a effet nefaste sur la biere
WO2000065093A3 (fr) Procedes d'hybridation in situ permettant de reduire l'occurrence de faux resultats positifs et de cibler des micro-organismes multiples
WO2004009843A3 (fr) Detection de micro-organismes
WO1999005159A3 (fr) Molecule d'acide nucleique specifique staphylococcus necessaire et son utilisation
WO2003048766A3 (fr) Essai et trousse d'essai calorimetrique servant a detecter la presence d'artemisinine et de derives d'artemisinine
WO2002057493A3 (fr) Methodes destinees a determiner la presence d'organismes et ne necessitant pas de separation de reactifs de fixation ou de sondes en exces
AU2001289547A1 (en) Method for determining the age of individuals
EP1188060A4 (fr) Procede et appareil pour l'affichage de donnees relatives a l'analyse de la thrombose et de l'hemostase
WO2001088186A3 (fr) Procedes de detection et d'identification de bacteries gram positives dans un echantillon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2412946

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 523396

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2001272629

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001951777

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 018150977

Country of ref document: CN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001951777

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10332123

Country of ref document: US

B Later publication of amended claims

Effective date: 20021115